– Initiated multiple trials with ARV-471, including a 2L+ Phase 3 trial for patients with metastatic breast cancer – – Presented Phase…
CHCM Will Conduct the Ultimate Competency Assessment WorkshopAtlanta, GA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- From March 14 to 17,…
Seeding Program Will Produce Tobacco for Up To 2 Billion Sticks – The Entire Annual Cigarette Consumption of New Zealand…
Companies partner to pair the power of drug companion apps with convenient diagnostic testingSAN JOSE, Calif., Feb. 22, 2023 (GLOBE…
NEW YORK, Feb. 22, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release…
New name, Greek for “zebra,” is the internationally-recognized symbol for the rare disease community Branding reflects Company’s commitment to making…
ASHBURN, Va., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage,…
Final draft guidance based on cost effectiveness evaluation of sotrovimabSAN FRANCISCO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc.…
DUBLIN, Ireland, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer…
Introducing the New Good Supply MONSTERS™ Pre-Rolls Now Available Across CanadaTORONTO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc.…